OP8 A New Complement Inhibitor: Impact of Ravulizumab on Eculizumab and Future Biosimilars Use, and Role of Paris Public Hospitals (AP-HP)
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2417
https://www.valueinhealthjournal.com/article/S1098-3015(23)05547-X/fulltext
Title :
OP8 A New Complement Inhibitor: Impact of Ravulizumab on Eculizumab and Future Biosimilars Use, and Role of Paris Public Hospitals (AP-HP)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05547-X&doi=10.1016/j.jval.2023.09.2417
First page :
Section Title :
Open access? :
No
Section Order :
11759